Erythropoietin may improve anemia in patients with autoimmune hemolytic anemia associated with reticulocytopenia. (odpre novo okno)

Arbach O, Funck R, Seibt F, Salama A.

Vir‎: Transfus Med Hemother 2012;39(3):221-3.

Indeksirano‎: PubMed 22851939

DOI‎: 10.1159/000339260

https://www.ncbi.nlm.nih.gov/pubmed/22851939 (odpre novo okno)

The changing spectrum of drug-induced immune hemolytic anemia. (odpre novo okno)

Arndt PA, Garratty G.

Vir‎: Semin Hematol 2005;42(3):137-44.

Indeksirano‎: PubMed 16041663

https://www.ncbi.nlm.nih.gov/pubmed/16041663 (odpre novo okno)

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies. (odpre novo okno)

Barcellini W, Zaja F, Zaninoni A, Imperiali FG, Battista ML, Di Bona E, Fattizzo B, Consonni D, Cortelezzi A, Fanin R, Zanella A.

Vir‎: Blood 2012;119(16):3691-7.

Indeksirano‎: PubMed 22267606

DOI‎: 10.1182/blood-2011-06-363556

https://www.ncbi.nlm.nih.gov/pubmed/22267606 (odpre novo okno)

Autoimmune hemolytic anemia. (odpre novo okno)

Gehrs BC, Friedberg RC.

Vir‎: Am J Hematol 2002;69(4):258-71.

Indeksirano‎: PubMed 11921020

https://www.ncbi.nlm.nih.gov/pubmed/11921020 (odpre novo okno)

Low-dose rituximab and alemtuzumab combination therapy for patients with steroid-refractory autoimmune cytopenias. (odpre novo okno)

Gómez-Almaguer D, Solano-Genesta M, Tarín-Arzaga L, Herrera-Garza JL, Cantú-Rodríguez OG, Gutiérrez-Aguirre CH, Jaime-Pérez JC.

Vir‎: Blood 2010;116(23):4783-5.

Indeksirano‎: PubMed 20841509

DOI‎: 10.1182/blood-2010-06-291831

https://www.ncbi.nlm.nih.gov/pubmed/20841509 (odpre novo okno)

A case of late-onset systemic lupus erythematosus with severe anemia. (odpre novo okno)

Matsumoto M, Kaieda S, Honda S, Ida H, Hoshino T, Fukuda T.

Vir‎: Kurume Med J 2013;60(1):25-8.

Indeksirano‎: PubMed 23925156

https://www.ncbi.nlm.nih.gov/pubmed/23925156 (odpre novo okno)

High-dose cyclophosphamide for refractory autoimmune hemolytic anemia. (odpre novo okno)

Moyo VM, Smith D, Brodsky I, Crilley P, Jones RJ, Brodsky RA.

Vir‎: Blood 2002;100(2):704-6.

Indeksirano‎: PubMed 12091370

DOI‎: 10.1182/blood-2002-01-0087

https://www.ncbi.nlm.nih.gov/pubmed/12091370 (odpre novo okno)

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia. (odpre novo okno)

Zecca M, De Stefano P, Nobili B, Locatelli F.

Vir‎: Blood 2001;97(12):3995-7.

Indeksirano‎: PubMed 11389047

https://www.ncbi.nlm.nih.gov/pubmed/11389047 (odpre novo okno)

Rituximab for the treatment of refractory autoimmune hemolytic anemia in children. (odpre novo okno)

Zecca M, Nobili B, Ramenghi U, Perrotta S, Amendola G, Rosito P, Jankovic M, Pierani P, De Stefano P, Bonora MR, Locatelli F.

Vir‎: Blood 2003;101(10):3857-61.

Indeksirano‎: PubMed 12531800

DOI‎: 10.1182/blood-2002-11-3547

https://www.ncbi.nlm.nih.gov/pubmed/12531800 (odpre novo okno)